Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients

Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients

Abstract Background To investigate whether the serum free thyroxine (FT4) level is a prognostic factor for the first-attack neuromyelitis optica spectrum disorders (NMOSD). Methods This retrospective study enrolled 109 patients with first-attack NMOSD. The Expanded Disability Status Scale (EDSS) and...

Full description

Bibliographic Details
Main Authors: Qianyi He, Lifeng Li, Yanfei Li, Yanhui Lu, Kaimin Wu, Ruiyi Zhang, Junfang Teng, Jie Zhao, Yanjie Jia
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Neurology
Subjects:
Serum free thyroxine
NMOSD
Prognosis
Relapse
EDSS
Online Access:https://doi.org/10.1186/s12883-019-1560-7

Similar Items

Similar Items